- Home
- DNTH vs REPX Comparison
DNTH vs REPX Comparison
Compare DNTH & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- REPX
- Stock Information
- Founded
- DNTH 2015
- REPX 2016
- Country
- DNTH United States
- REPX United States
- Employees
- DNTH N/A
- REPX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- REPX Oil & Gas Production
- Sector
- DNTH Health Care
- REPX Energy
- Exchange
- DNTH Nasdaq
- REPX Nasdaq
- Market Cap
- DNTH 724.8M
- REPX 734.3M
- IPO Year
- DNTH N/A
- REPX N/A
- Fundamental
- Price
- DNTH $23.67
- REPX $33.59
- Analyst Decision
- DNTH Strong Buy
- REPX Strong Buy
- Analyst Count
- DNTH 9
- REPX 1
- Target Price
- DNTH $46.43
- REPX $47.00
- AVG Volume (30 Days)
- DNTH 198.9K
- REPX 92.1K
- Earning Date
- DNTH 03-20-2025
- REPX 03-05-2025
- Dividend Yield
- DNTH N/A
- REPX 4.51%
- EPS Growth
- DNTH N/A
- REPX 12.34
- EPS
- DNTH N/A
- REPX 5.64
- Revenue
- DNTH $5,366,000.00
- REPX $407,315,000.00
- Revenue This Year
- DNTH $100.14
- REPX $11.73
- Revenue Next Year
- DNTH N/A
- REPX $4.83
- P/E Ratio
- DNTH N/A
- REPX $5.97
- Revenue Growth
- DNTH 51.41
- REPX 15.30
- 52 Week Low
- DNTH $18.35
- REPX $22.60
- 52 Week High
- DNTH $33.77
- REPX $37.55
- Technical
- Relative Strength Index (RSI)
- DNTH 53.31
- REPX 48.15
- Support Level
- DNTH $22.77
- REPX $33.03
- Resistance Level
- DNTH $25.46
- REPX $36.18
- Average True Range (ATR)
- DNTH 1.49
- REPX 1.34
- MACD
- DNTH 0.13
- REPX 0.07
- Stochastic Oscillator
- DNTH 57.18
- REPX 43.20
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties, and Tennessee Properties, among others.